Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MiraMSC-FS-001
- Development stage
- Phase 1
- Lead developer
- Miracle Biomedical
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
MiraMSC-FS-001 is an investigational cell therapy product consisting of allogeneic umbilical cord-derived mesenchymal stem cells (UCMSCs). Developed by Miracle Biomedical Co., Ltd., it is being evaluated for the treatment of frailty syndrome in elderly populations. Mesenchymal stem cells are known for their potent immunomodulatory, anti-inflammatory, and regenerative properties, which are hypothesized to address the chronic low-grade systemic inflammation (often termed inflammaging) and tissue degeneration associated with frailty. The product is administered via intravenous infusion and is currently in Phase I clinical development to assess its safety, tolerability, and preliminary efficacy in older adults with mild to moderate frailty syndrome.
- Other names
- allogeneic umbilical cord-derived mesenchymal stem cellsUCMSCs
Beyond the preview
Go deeper on MiraMSC-FS-001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MiraMSC-FS-001.